JPH1087578A5 - - Google Patents
Info
- Publication number
- JPH1087578A5 JPH1087578A5 JP1997232477A JP23247797A JPH1087578A5 JP H1087578 A5 JPH1087578 A5 JP H1087578A5 JP 1997232477 A JP1997232477 A JP 1997232477A JP 23247797 A JP23247797 A JP 23247797A JP H1087578 A5 JPH1087578 A5 JP H1087578A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- oso2
- oar
- oco
- pyrrolidinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2512796P | 1996-08-29 | 1996-08-29 | |
| US60/025127 | 1996-08-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1087578A JPH1087578A (ja) | 1998-04-07 |
| JPH1087578A5 true JPH1087578A5 (enExample) | 2005-05-26 |
Family
ID=21824198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9232477A Withdrawn JPH1087578A (ja) | 1996-08-29 | 1997-08-28 | ナフタレン化合物、中間体、製剤、及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0826670B1 (enExample) |
| JP (1) | JPH1087578A (enExample) |
| CA (1) | CA2213814A1 (enExample) |
| DE (1) | DE69712425T2 (enExample) |
| ES (1) | ES2176626T3 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7467398A (en) * | 1997-04-25 | 1998-11-24 | Eli Lilly And Company | Indene compounds having activity as serms |
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| WO2004009086A1 (en) | 2002-07-22 | 2004-01-29 | Eli Lilly And Company | Selective estrogen receptor modulators containing a phenylsulfonyl group |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7501441B1 (en) * | 1994-09-20 | 2009-03-10 | Eli Lilly And Company | Naphthyl compounds, intermediates, processes, compositions, and methods |
| US5484798A (en) * | 1994-09-20 | 1996-01-16 | Eli Lilly And Company | Benzothiopene compounds, compositions, and method of inhibiting restenosis |
| US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
| US6391892B1 (en) * | 1995-03-10 | 2002-05-21 | Eli Lilly And Company | Naphthyl pharmaceutical compounds |
| US6451817B1 (en) * | 1995-03-10 | 2002-09-17 | Eli Lilly And Company | Alpha-substituted-1-benzyl-napthyls |
| US5811421A (en) * | 1995-07-31 | 1998-09-22 | Eli Lilly And Company | Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
-
1997
- 1997-08-25 CA CA002213814A patent/CA2213814A1/en not_active Abandoned
- 1997-08-27 EP EP97306560A patent/EP0826670B1/en not_active Expired - Lifetime
- 1997-08-27 DE DE69712425T patent/DE69712425T2/de not_active Expired - Fee Related
- 1997-08-27 ES ES97306560T patent/ES2176626T3/es not_active Expired - Lifetime
- 1997-08-28 JP JP9232477A patent/JPH1087578A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002513793A5 (enExample) | ||
| JPH1087577A5 (enExample) | ||
| IL115335A (en) | Naphthyl compounds process for their preparation and pharmaceutical compositions thereof | |
| JP2020169171A5 (enExample) | ||
| JP2005508962A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| RU95120569A (ru) | Новые производные 5-пирролил-2-пиридилметилсульфинил-бензимидазола | |
| JPH10279578A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JPH1095778A5 (enExample) | ||
| CA2440014A1 (en) | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety | |
| JP2004525178A5 (enExample) | ||
| DE69532079D1 (de) | Benzofuranverbindungen, präparate und verfahren | |
| DE69707611D1 (de) | Dihydronaphthalen- und Naphthalenderivate, Zwischenverbindungen, Zusammensetzungen und deren Herstellungsverfahren | |
| JPH1087578A5 (enExample) | ||
| EP0826679A3 (en) | Naphthyl compounds, intermediates, compositions, and method of use | |
| JPH1036365A5 (enExample) | ||
| JPH10130211A5 (enExample) | ||
| JP2003509494A5 (enExample) | ||
| JP2002535406A5 (enExample) | ||
| CA2576067A1 (en) | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof | |
| KR970705999A (ko) | 타목시펜 및 타목시펜 유사체의 자궁향성 효과를 최소화시키는 방법 (a method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs) | |
| KR900009596A (ko) | N-피리디닐-9h-카바졸-9-아민, 이의 제조방법 및 이의 약제로서의 용도 | |
| JP2003535868A5 (enExample) | ||
| JPH10130260A5 (enExample) |